Navigation Links
GeneNews Announces Second Quarter Results
Date:8/7/2008

term debt 983,081 1,280,916

Long-term portion of deferred revenue - 401,371

-------------------------------------------------------------------------

Total liabilities 4,283,751 5,171,648

-------------------------------------------------------------------------

Shareholders' equity

Capital stock 44,542,030 44,290,930

Contributed surplus 3,228,101 2,733,562

Deficit (39,929,240) (33,348,130)

-------------------------------------------------------------------------

Total shareholders' equity 7,840,891 13,676,362

-------------------------------------------------------------------------

12,124,642 18,848,010

-------------------------------------------------------------------------

-------------------------------------------------------------------------

CONSOLIDATED STATEMENTS OF OPERATIONS

AND DEFICIT

(Unaudited)

(Expressed in Canadian dollars)

Three months Three months Six months Six months

ended ended ended ended

June 30 June 30 June 30 June 30

2008 2007 2008 2007

-------------------------------------------------------------------------

Revenue

Milestones $ 288,438 $ - $ 582,724 $ 1,666,236

-------------------------------------------------------------------------

288,438 - 582,724 1,666,236

<
'/>"/>
SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. GeneNews Announces First Quarter Results
9. Genenews adds two members to its Board of Directors
10. GeneNews announces management changes to support commercialization of ColonSentry(TM)
11. GeneNews launches worlds first blood test for colorectal cancer screening
Post Your Comments:
*Name:
*Comment:
*Email: